Advisory Board September 24, 2024

Under a new Louisiana law, which goes into effect Oct. 1, mifepristone and misoprostol will be classified as controlled substances, a decision that healthcare providers say could negatively impact patient care.

Resource library: Women’s health

Louisiana classifies abortion drugs as controlled substances

This spring, Louisiana passed a law classifying mifepristone and misoprostol as controlled substances, making it the first state to do so. The two drugs are commonly used in pregnancy and reproductive healthcare, including for abortion.

Under the law, which goes into effect Oct. 1, a person who obtains the drugs “for her own consumption” would not face prosecution, but anyone helping them, with the exception of a healthcare provider writing or filling a valid prescription, would. Individuals...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Patient / Consumer, Provider, States
GenAI is already transforming the healthcare industry
Where Medicaid cuts stand
Q&A: Rural hospitals need help with cybersecurity survival
Radiology provider MedQuest part of deal to acquire 18 imaging centers from 1 of nation’s largest orthopedic groups
ASC block utilization by specialty

Share This Article